Soft quarter with profit decline; strategic positioning intact but execution at risk

Claim not contradicted by results but deals in early execution; TIG segment declined QoQ

No size disclosed; execution impact deferred as project ramps over 12-18 months

TIG segment (includes data center) declined sequentially; large deal execution ramping slowly

Revenue +3.6% QoQ; but PAT -26.6% QoQ shows profit quality deterioration despite revenue growth

Banking grew only ~5% despite higher capacity allocation; EBITDA margin 17% vs prior ~20-22% range

Order book validated by large wins, but conversion below normal trajectory (timing, capacity, project ramps)

Expected significant banking growth from MEA last year; instead 'came down to zero' due to geopolitical crisis. Mgmt pivoting to Southeast Asia, Europe but no concrete wins reported yet.

Increased investment in AI-native banking 2.0 stack build (Arya.AI, Lexi labs, trade finance). Temporary margin pressure acknowledged; claimed to normalize in 1-2 quarters.

Labeled 'inflection point' with growth potential 50-100% in FY27 vs. prior 40-50%. But sequential TIG decline in Q1 contradicts this. Ramp delayed but pipeline 'very large'.

No recalibration to prior 20-22% EBITDA guidance despite Q1 17% EBITDA and 10-11% R&D spend. Data center expected to remain 4-5 points below enterprise margin for multi-year horizon.

Repeated claim of H2 acceleration (made annually last 5 years, true 4/5 years but false last year). CEO explicitly flagged this risk and vowed 'greater discipline' on execution.

Deal is very large with components not immediately translating to revenue. Expect pickup in Q2, significant acceleration in Q3-Q4. It takes time to ramp large projects.

No pass-through, all internal capacity. Deal contributing but ramp is slow quarter-to-quarter. Banking margin decline due to product R&D (AI stack), not deal structure. Should normalize next 1-2 quarters.

Banking generally remains profitable; margin drop is function of revenue and R&D allocation, not business fundamentals. As software becomes larger/more global, operating leverage will improve over 3-5 years.

No specific guidance. Sequential growth Q1-to-Q1 this year stronger than most years. Accelerating, especially in H2. No specific numbers given.

Not closed yet. Things progressing more than Q4 but still slow. Hopeful to announce wins in next 1-2 quarters. Statement that deals haven't closed stands true.

Yes, built capacity in advance due to visibility to pipeline demand (beyond just announced deal). Data center remains 4-5 points below enterprise margin; multi-year play to improve via IP productization, not near-term.

Mix likely 55-45 to 56-44 banking-to-TIG (no dramatic change this year). Data center growth 50-100% expected; will become ~40% of TIG by year-end (from ~33% now).

R&D to remain at 10.5-11% of revenue; some projects reaching natural end-of-life, may decline slightly post H1. No major change expected.

MEA is question mark; banking expected significant contribution but came to zero. Refocusing on Southeast Asia (transaction banking), Europe (meaningful wins expected). No clear timeline on MEA; will normalize by Q3 YoY comp but ongoing disruption uncertain.

Data center is lower-margin but high-volume, returns high ROI. Software will improve margins with operating leverage. R&D spend continues. Not worried about a few margin points down; net contribution to enterprise strong. Multi-year view necessary.

Not slowing sales; transaction banking win rates >50% in markets we serve. Productivity gains from AI tools offsetting capacity diversion over 4-5 quarters. Won't hire-and-fire; people-centric org. Execution track record shows we win more than we lose.

Not stuck in range. Q1 size is what Aurionpro was 4-5 years ago; company has grown 400-500 Cr to current size progressively. Capacity build takes time in complex projects. Continue to execute quarter-by-quarter.

Focused on cash conversion this year. Order book to revenue AND EBITDA-to-cash conversion are extreme focus. Historically H1 is negative/close-to-zero OCF due to payment cycles. Hopeful for good number. Acquisitions paused, R&D not increasing, should ease cash pressure.

Disagree. Data center will contribute but not the only source. Transit will grow. Banking will grow. Multi-year execution on data center deal anyway. Question is how much, will report as year progresses.

Management declined to provide numbers citing execution uncertainties, MEA disruption, and large project timing variability. Historical pattern: claimed H2 acceleration annually; true 4 of past 5 years but false last year.

Q1 EBITDA 17% vs. implied 20-22% prior guidance. Management attributes 300-400 bps margin pressure to banking R&D (AI stack) and data center build. Claims normalization in 1-2 quarters but no numeric recalibration offered.

Management positioning data center as high-volume, lower-margin business. Expects productization to improve margins incrementally over 3-5 years (similar to transit journey).

Stated in prior guidance; no change communicated. Capacity buildout for data center, AI tooling for development & implementation ongoing. No M&A acquisitions planned next few quarters frees up cash deployment.

Management guided data center deal in 'inflection'; TIG declined QoQ. Large deals take 12-18 months to convert; capacity buildout happens slowly. Sequential decline contradicts inflection narrative; raises doubt on acceleration timing.

Last year MEA contributed double-digit % of revenue; this year 'came down to zero' on banking side due to West Asia crisis. Mgmt hoped for Q4 deals to close; they didn't. Drag visible through Q3 despite 'things progressing better than Q4'.

Q1 EBITDA 17% vs. prior 20-22% guidance. PAT declined 11.1% YoY despite 6.3% revenue growth. R&D spend at 10.5-11% remains stable. Banking R&D (AI stack) expected to normalize in 1-2 quarters but no concrete milestones offered.

CEO explicitly acknowledged: 'I have made the same statement about accelerating in second half for the last several years but last year it wasn't true.' Projects 'meaningful acceleration' in H2 FY27 despite weak Q1. Q3-Q4 will be critical test.

Analyst Tejas Gutka flagged: revenue plateau contradicts claimed scale investments. Management countered that Q1 is what Aurionpro was 4-5 years ago; company has grown 400-500 Cr progressively. However, near-term ROI on employee investment unclear.